{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:07:02Z","timestamp":1762528022779,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000640","name":"Institute of Physics","doi-asserted-by":"publisher","award":["3D"],"award-info":[{"award-number":["3D"]}],"id":[{"id":"10.13039\/501100000640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ajoc.2022.101753","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:55:48Z","timestamp":1668192948000},"page":"101753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Parafoveal acute middle maculopathy (PAMM) in sickle cell disease after discontinuation of hydroxyurea"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5996-6959","authenticated-orcid":false,"given":"Pooja","family":"Parikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Bat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alecia","family":"Nero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5552-371X","authenticated-orcid":false,"given":"Angeline","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9703-5047","authenticated-orcid":false,"given":"Sean G.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8022-5119","authenticated-orcid":false,"given":"Rafael L.","family":"Ufret-Vincenty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajoc.2022.101753_bib1","first-page":"1275","article-title":"Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia","volume":"131","author":"Sarraf","year":"2013","journal-title":"JAMAOphthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101753_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/ICU.0000000000000045","article-title":"Paracentral acute middle maculopathy spectral-domain optical coherence tomography feature of deep capillary ischemia","volume":"25","author":"Rahimy","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101753_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ajo.2014.09.027","article-title":"The spectrum of superficial and deep capillary ischemia in retinal artery occlusion","volume":"159","author":"Yu","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101753_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/ICB.0000000000000679","article-title":"Paracentral acute middle maculopathy in pregnancy","volume":"14","author":"Chen","year":"2020","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajoc.2022.101753_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3928\/15428877-20061101-12","article-title":"Optical coherence tomography findings in central retinal artery occlusion","volume":"37","author":"Falkenberry","year":"2006","journal-title":"Ophthalmic Surg Laser Imag"},{"key":"10.1016\/j.ajoc.2022.101753_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5301\/ejo.5000033","article-title":"Localized foveal detachment in a patient with central retinal artery occlusion with cilioretinal sparing","volume":"22","author":"Ozdemir","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101753_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00417-008-0791-x","article-title":"Changes in retinal thickness are correlated with alterations of electroretinogram in eyes with central retinal artery occlusion","volume":"246","author":"Shinoda","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajoc.2022.101753_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bjophthalmol-2018-312774","article-title":"Cilioretinal artery hypoperfusion and its association with paracentral acute middle maculopathy","volume":"103","author":"Pichi","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajoc.2022.101753_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/archopht.1976.03910040227015","article-title":"Cilioretinal arteries. A study based on review of stereo fundus photographs and fluorescein angiographic findings","volume":"94","author":"Justice","year":"1976","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101753_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ajo.2015.01.001","article-title":"Retinal and choroidal changes and visual outcome in central retinal artery occlusion: an optical coherence tomography study","volume":"159","author":"Ahn","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101753_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archopht.1991.01080030041034","article-title":"A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization","volume":"109","author":"Duker","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101753_bib12","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/112067211002000603","article-title":"Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset","volume":"20","author":"Rudkin","year":"2010","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101753_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.preteyeres.2011.05.001","article-title":"Acute retinal arterial occlusive disorders","volume":"30","author":"Hayreh","year":"2011","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101753_bib14","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00415-021-10838-6","article-title":"Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis","volume":"269","author":"Huang","year":"2022","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101753_bib15","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000366","volume":"52","author":"Mac Grory","year":"2021","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101753_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","article-title":"Vipul N. Mankad, and investigators of the cooperative study of sickle cell disease. \"Causes of death in sickle cell disease: an autopsy study","volume":"123","author":"Manci","year":"2003","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101753_bib17","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.ophtha.2015.07.018","article-title":"Risk and risk periods for stroke and acute myocardial infarction in patients with central retinal artery occlusion","volume":"122","author":"Park","year":"2015","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101753_bib18","doi-asserted-by":"crossref","first-page":"P259","DOI":"10.1016\/j.ophtha.2019.09.028","article-title":"Retinal and ophthalmic artery occlusions preferred practice pattern","volume":"127","author":"Fawzi","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101753_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajh.21569","article-title":"Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease","volume":"85","author":"Fitzhugh","year":"2010","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101753_bib20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.hoc.2005.07.006","article-title":"Overt and incomplete (silent) cerebral infarction in sickle cell anemia: diagnosis and management","volume":"19","author":"Wong","year":"2005","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.ajoc.2022.101753_bib21","first-page":"S2468","article-title":"Association of acute macular neuroretinopathy or paracentral acute middle maculopathy with sickle cell disease","volume":"21","author":"Ong","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101753_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1179\/146532810X12637745451870","article-title":"Ocular manifestations of sickle cell disease","volume":"30","author":"Fadugbagbe","year":"2010","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.ajoc.2022.101753_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-216124","article-title":"Paracentral acute middle maculopathy: precursor to macular thinning in sickle cell retinopathy","volume":"2017","author":"Hussnain","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"7","key":"10.1016\/j.ajoc.2022.101753_bib24","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1167\/iovs.18-24112","article-title":"Projection-resolved OCT angiography of microvascular changes in paracentral acute middle maculopathy and acute macular neuroretinopathy","volume":"59","author":"Chu","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2022.101753_bib25","doi-asserted-by":"crossref","first-page":"359e377","DOI":"10.1016\/j.survophthal.2009.11.004","article-title":"Sickle cell disease and the eye: old and new concepts","volume":"55","author":"Elagouz","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101753_bib26","doi-asserted-by":"crossref","first-page":"1869e1875","DOI":"10.1016\/j.ophtha.2005.05.026","article-title":"Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study","volume":"112","author":"Downes","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2022.101753_bib27","doi-asserted-by":"crossref","first-page":"32e42","DOI":"10.1016\/j.blre.2019.03.001","article-title":"Sickle cell retinopathy: what we now understand using optical coherence tomography angiography. A systematic review","volume":"35","author":"Leitao Guerra","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.ajoc.2022.101753_bib28","doi-asserted-by":"crossref","first-page":"1939e1945","DOI":"10.1038\/s41433-019-0499-7","article-title":"Multifocal electroretinogram findings in sickle cell maculopathy","volume":"33","author":"Beral","year":"2019","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101753_bib29","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2019.040","article-title":"Sickle cell disease and pregnancy","volume":"11","author":"Jain","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101753_bib30","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.ajog.2008.04.016","article-title":"Morbidity associated with sickle cell disease in pregnancy","volume":"199","author":"Villers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"year":"2011","series-title":"Management of Sickle Cell Disease in Pregnancy","author":"No","key":"10.1016\/j.ajoc.2022.101753_bib31"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101753_bib33","first-page":"143","article-title":"In utero morphological effects of hydroxyurea on the fetal development in Sprague-Dawley rats","volume":"36","author":"Asano","year":"1987","journal-title":"Jikken Dobutsu"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101753_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/tera.1420200314","article-title":"A teratogenicity study on hydroxyurea and diphenylhydantoin in cats","volume":"20","author":"Khera","year":"1979","journal-title":"Teratology"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101753_bib35","doi-asserted-by":"crossref","first-page":"e584","DOI":"10.1097\/HS9.0000000000000584","article-title":"Research in sickle cell disease: from bedside to bench to bedside","volume":"5","author":"Salinas Cisneros","year":"2021","journal-title":"Hemasphere"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101753_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajh.26495","article-title":"Sickle Cell Disease Implementation Consortium. Pregnancy outcomes with hydroxyurea use in women with sickle cell disease","volume":"97","author":"Kroner","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajoc.2022.101753_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1096-8652(199806)58:2<117::AID-AJH5>3.0.CO;2-V","article-title":"Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential","volume":"58","author":"Niihara","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajoc.2022.101753_bib38","first-page":"4","article-title":"L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells","volume":"5","author":"Niihara","year":"2005","journal-title":"BMC Blood Disord"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101753_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/phar.2405","article-title":"Systematic review of voxelotor: a first-in-class sickle hemoglobin polymerization inhibitor for management of sickle cell disease","volume":"40","author":"Han","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101753_bib40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1060028020943059","article-title":"Voxelotor: a novel treatment for sickle cell disease","volume":"55","author":"Herity","year":"2021","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101753_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40265-019-01254-2","article-title":"Crizanlizumab: first approval","volume":"80","author":"Blair","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ajoc.2022.101753_bib42","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1471-0528.1995.tb10900.x","article-title":"Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome","volume":"102","author":"Howard","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101753_bib43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bjh.14383","article-title":"Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion","volume":"176","author":"Davis","year":"2017","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101753_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9394(00)00778-9","article-title":"Sickle cell disease presenting with extensive peri-macular arteriolar occlusions in a nine-year-old boy","volume":"131","author":"Al-Abdulla","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101753_bib45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/1752-1947-8-370","article-title":"Hyperbaric oxygen therapy in combination with systemic treatment of sickle cell disease presenting as central retinal artery occlusion: a case report","volume":"8","author":"Canan","year":"2014","journal-title":"J Med Case Rep"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101753_bib46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3928\/23258160-20130909-18","article-title":"Reversal of paracentral occlusive retinopathy in a case of sickle cell disease using exchange transfusion","volume":"44","author":"Gustave","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101753_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00006982-198500540-00007","article-title":"Exchange transfusion in sickling maculopathy","volume":"5","author":"Khwarg","year":"1985","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ajoc.2022.101753_bib48","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.4103\/njcp.njcp_95_17","article-title":"Bilateral simultaneous macular infarction with spontaneous visual recovery in genotype ss hemoglobinopathy patient","volume":"20","author":"Okonkwo","year":"2017","journal-title":"Niger J Clin Pract"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101753_bib49","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/17474086.2014.959922","article-title":"Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review","volume":"7","author":"DeBaun","year":"2014","journal-title":"Expet Rev Hematol"},{"issue":"12","key":"10.1016\/j.ajoc.2022.101753_bib50","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2009-05-221333","article-title":"The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)","volume":"115","author":"Voskaridou","year":"2010","journal-title":"Blood"},{"year":"2022","series-title":"Data & Statistics on Sickle Cell Disease","key":"10.1016\/j.ajoc.2022.101753_bib51"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622004996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622004996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:01:40Z","timestamp":1762527700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993622004996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":50,"alternative-id":["S2451993622004996"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101753","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parafoveal acute middle maculopathy (PAMM) in sickle cell disease after discontinuation of hydroxyurea","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101753"}}